Features
Bioprospecting
A Brief History
Methods and Goals
Who is Bioprospecting?
Governance
Biopiracy
An Overview
Who is Biopirating?
Case Studies
Success in Panama
Biopiracy in Chiapas
Middle Ground in Tanzania
Concluding Remarks
Differences and Similarities
|
|
 |
Bioprospecting: An Overview
What is it, and who does it affect?
As the
world becomes more globalized and science more technologically complicated, it
is increasingly harder to come to consensus about scientific controversies.
Some controversies are engulfed by morality and ethics debates, such as genetic
engineering. Others, like nuclear power, reflect conflicts of power, safety,
and global impacts. When these overlap, issues of power relationships,
locational scale, and ethics come together into one scientific arena.
Bioprospecting is one such example; it is the practice of searching rich
biodiverse regions for new chemical compounds within species. Usually taking
plants from the developing world, bioprospecting commonly seeks new compounds
to aid the medical world. In the best case scenarios, bioprospecting agreements
work with the local communities to share knowledge about biological life,
benefits from research, and conservation goals.
Unfortunately,
there are many opportunities for well-intentioned bioprospecters to stray from
their goals. For such occurrences, activists opposed to bioprospecting have
claimed the term biopiracy. In these cases, the scientists or researchers
ignore the needs of local communities, and 'pirate' the natural resources of a
region. Without contributing back to the local economy, and exploiting the
knowledge of local healers and leaders, the leaders of biopiracy expeditions
are condemned in the indigenous rights activist community for perpetuating
colonialist attitudes and imperialist use of resources. The term 'biopiracy'
has such strong connotations, and thus condemnation of parties lends a
particular narrative to the anti-biopiracy movement. The images associated with
perpetrators are those of pillaging, stealing, and ravaging. This has had
specific impacts on concerned citizens, and has led to much action against the
organizations accused of biopiracy.
Through
corporate boycotting, protesting, or letter-writing, citizens in the US
and
global North can, and have influenced their businesses. On the local
scale,
indigenous communities can come together and determine the appropriate
amount
of outsider influence in their lands. Activists groups have been
mobilizing
across the world to protest the patenting of biological life in
general, and
especially exploitative biopiracy practices. In light of so much
activism and
protest, it is important to explore whether bioprospecting can ever be
done
effectively and equitably. If there is room for appropriate,
respectful, and
equitable action, then bioprospecting could potentially benefit all
parties involved. It would help the medical world, the development of
third world communities, and
conservation efforts. With so much variation between success and
failure, the
governance leading to each scenario must be explored to understand how
bioprospecting can guarantee the most people the most equal and fair
outcomes.
This
website will seek to compare two detailed case studies and their outcomes. The
first case study, in Panama, was a successful bioprospecting agreement, where
all parties involved seemed benefit as much as possible. The second case, in
Chiapas, Mexico, demonstrates a place where local residents refused to allow
scientists and outsiders into their land to take their wildlife, because they
saw it as a threat to their sovereignty. A political ecology framework will be used to analyze these case studies,
because it is a valuable way to consider issues of power, scale, knowledge, and
discourse. This framework helps to explain how different perceptions of
knowledge and its values contribute to different governance, motives, and
conclusions. Throughout each case study, compare how the perception and value
of knowledge, on both the bioprospecting side and the local side, both work to
impact the discourse that is carried out about the projects. The impacts of the
media vary greatly with the scale of the cases, and this has much to do with
the type of discourse: positive bioprospecting claims tend to be academic,
while criticisms of biopiracy are more citizen-friendly and web-based.
Finally,
there are many more models that are possible for bioprospecting. These will
briefly be addressed throughout the website, but not as thoroughly as the two
main examples. Remember that there are many opportunities for bioprospecting
agreements to change their course, and either fall into a case of biopiracy, or
just not follow through on stated goals. There are also more localized cases of
bioprospecting that are going on, though these are less common and also less
the focus of academic and corporate interest. Please be aware of similarities
and differences throughout the website, and follow the links if you are
interested in more information!
|
The Cornell University professor
Thomas Eisner coined the term "bioprospecting" in 1989. He describes it
as, "the systematic search for secondary metabolites with potentially
therapeutic properties as a strategy for creating economic incentives for conserving biological diversity" (Eisner 1989). In
other words, bioprospecting today is understood as a two-way process
that both searches for medical products in biologically diverse regions, and promotes conservation through economic incentives. |